Epi-Q (United States)

Recent papers from Epi-Q (United States)

1. A Discrete Choice Experiment of Clinician Preferences Among Attributes of Approved Janus Kinase Inhibitors for Alopecia AreataAdvances in Therapy · 2026
2. Patient preferences for treatment characteristics of Janus kinase inhibitors for alopecia areata: a discrete choice experimentJournal of Dermatological Treatment · 2026
3. Expanding access and comprehensive care in the management of patients with inflammatory bowel disease with pharmacy servicesAmerican Journal of Health-System Pharmacy · 2026
4. Efficient Calibration Strategy for Crystal Plasticity Constitutive Law to Model Additively Manufactured AlloysIntegrating materials and manufacturing innovation · 2025
5. A validation study of the Clinician's Tardive Inventory (CTI)Parkinsonism & Related Disorders · 2025
6. Avelumab First-Line Maintenance for Locally Advanced or Metastatic Urothelial Carcinoma: Results From the Real-World US PATRIOT-II StudyClinical Genitourinary Cancer · 2024
7. Patient, Care Partner, and Physician Voices in Treatment Decision-Making for Multiple MyelomaPatient Preference and Adherence · 2024
8. Patient and care partner perspectives and preferences related to myasthenia gravis treatment: A qualitative studyHealth Science Reports · 2024
9. Economic burden of patients with post-surgical chronic and transient hypoparathyroidism in the United States examined using insurance claims dataOrphanet Journal of Rare Diseases · 2024
10. Major clinical events and healthcare resource use among patients with long-chain fatty acid oxidation disorders in the United States: Results from LC-FAOD odyssey programMolecular Genetics and Metabolism · 2024
11. Racial and Ethnic Disparities in Patients With Inflammatory Bowel Disease: An Online SurveyInflammatory Bowel Diseases · 2023
12. Reduced Heart Failure-Related Healthcare Costs with Furoscix Versus in-Hospital Intravenous Diuresis in Heart Failure Patients: The FREEDOM-HF StudyFuture Cardiology · 2023
13. Health-related quality of life and treatment satisfaction in Chronic Lymphocytic Leukemia (CLL) patients on ibrutinib compared to other CLL treatments in a real-world US cross sectional studyPLoS ONE · 2022
14. Real-world Clinical Outcomes of First-Line Ibrutinib or Chemoimmunotherapy in Patients with Chronic Lymphocytic Leukemia by Risk StatusAdvances in Therapy · 2022
15. Prospective Evaluation of Exacerbations Associated with Suboptimal Peak Inspiratory Flow Among Stable Outpatients with COPDInternational Journal of COPD · 2022
16. HIV-associated wasting prevalence in the era of modern antiretroviral therapyAIDS · 2021
17. Efficacy of non-opioid analgesics to control postoperative pain: a network meta-analysisBMC Anesthesiology · 2020
18. Efficacy of non-opioid analgesics to control postoperative pain: A network meta-analysis2020
19. Development of a patient decision aid for treatment resistant depressionJournal of Affective Disorders · 2020
20. Efficacy of non-opioid analgesics to control postoperative pain: A network meta-analysis2020